Changes in the Gut Microbiome Associated with Intussusception in Patients with Peutz-Jeghers SyndromeOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the gut microbiome of patients with Peutz-Jeghers syndrome (PJS), a rare hereditary disorder marked by intestinal polyposis and a high risk of intussusception. Researchers used 16S rRNA sequencing to characterize overall microbiome composition and metagenomic sequencing on a subset of samples to assess functional pathway changes. The goal was to determine whether gut microbiota imbalance is associated with PJS and, specifically, with the complication of intussusception.
Who was studied?
Stool samples were collected from 168 patients with PJS and 68 healthy family members who lived in the same household. For the deeper metagenomic functional analysis, a representative subset of 61 PJS patients and 27 healthy family members was used. Using cohabitating relatives as controls helps account for shared diet and environment.
What were the most important findings?
The fecal microbiome of PJS patients showed greater variation in beta-diversity compared with healthy family members. PJS patients had an enhancement of Escherichia coli and a reduction of Faecalibacterium prausnitzii, an anti-inflammatory, butyrate-associated commensal. Among PJS patients, those with intussusception showed a further reduction in Faecalibacterium prausnitzii, marking it as a distinguishing microbial feature of this complication. Functional analysis found propanoate metabolism enriched in PJS patients overall and further enriched in those with intussusception, with Escherichia coli identified as the major contributor to this pathway.
What are the greatest implications of this study?
These findings suggest gut microbiome imbalance, particularly loss of Faecalibacterium prausnitzii and expansion of Escherichia coli, may play a role in PJS pathogenesis and specifically in the development of intussusception. The progressive depletion of this anti-inflammatory commensal alongside enriched propanoate metabolism points to a possible microbial signature that could help identify PJS patients at greater risk for this complication. This raises the possibility that restoring depleted commensals or targeting E. coli-driven metabolic pathways could be explored as future strategies, though the abstract does not report interventional data.